JCERT on Track for $1.16B in Economic Impact, Study Shows

In its first decade, JCERT returns more than $64M per year in economic impact

Jcert 10 year impact

The Johnson County Education Research Triangle marked its 10-year milestone by announcing significant economic returns for the Kansas City area.

Since it was enacted in 2009, the ⅛-cent JCERT sales tax has generated approximately $15.5 million per year on average. An economic impact study, commissioned by the JCERT Authority and conducted by Mid-America Regional Council in mid-2019, found that JCERT returns an average of more than $64 million per year in economic impact.

The study evaluated the economic benefits flowing from the investments made and programs created utilizing dollars from the JCERT tax. The value of the estimated increase in the region’s GDP created by JCERT is expected to be nearly $900 million, and the increase in personal income is expected to total more than $255 million, for a total of $1.155 billion over 18 years (2010-2028).

MARC worked closely with the three JCERT partners – the KU Edwards Campus, K-State Olathe and the University of Kansas Cancer Center – to determine appropriate economic measurements. Because MARC kept the size of JCERT-funded programs constant in terms of revenues, employment and graduates at the 2018 levels provided by the partner institutions, these likely are conservative estimates of the impact going forward.

Beyond its quantitative results, JCERT has delivered qualitative value. For example:

  • Human and animal health research is receiving a shot of adrenaline thanks to a unique collaboration between faculty, graduate and undergraduate students at K-State Olathe, K-State’s Manhattan campus and the University of Missouri-Kansas City. The first-of-a-kind project, 1Data, will shorten the time for a successful drug to reach the market. The project began in 2017 and is housed at K-State Olathe.
  • Corina Ramirez, a mother of two young children, was diagnosed with colon cancer in 2015. By 2018, her cancer was no longer responding to chemotherapy. She contacted the KU Cancer Center, the region’s only National Cancer Institute-designated cancer center. There, Ramirez enrolled in an innovative immunotherapy clinical trial. She knew almost immediately the treatment was working, and today has hope she will live to see her children grow into adulthood. (Dr. Roy Jensen, director of The University of Kansas Cancer Center, regularly credits JCERT with contributing to the KU Cancer Center receiving its NCI designation.)

Other benefits to the community are not strictly measurable in financial terms, such as outreach efforts, facilities available for public use, access to potentially life-saving clinical trials, prestige, expanded access to education and more.

Read the complete study.